Nonsteroidal Antiinflammatories

Small Animal Toxicology

Volumn , Issue , 2006, Pages 902-933

  Talcott, Patricia A ^a  

^a UNIVERSITY OF IDAHO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845410696     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-160639-3/50067-8     Document Type: Chapter

References (129)

1. Boothe DM Controlling inflammation with nonsteroidal anti-inflammatory drugs. Vet Med 1989, Sept:875-883.
2. Isaacs JP Adverse effects of non-steroidal anti-inflammatory drugs in the dog and cat. Aust Vet Pract 1996, 26(4):180-186.
3. Godshalk CP, Roush JK, Fingland RB, et al. Gastric perforation associated with administration of ibuprofen in a dog. J Am Vet Med Assoc 1992, 201(11):1734-1736.
4. Rubin SI, Papich MG Clinical uses of nonsteroidal anti-inflammatory drugs in companion animal practice. part II, drugs, therapeutic uses and adverse effects. Canine Pract 1992, 15(2):27-33. 1990.
5. Jackson TW, Costin C, Link K, et al. Correlation of serum ibuprofen concentration with clinical signs of toxicity in three canine exposures. Vet Hum Toxic 1991, 33(5):486-488.
6. Spyridakis LK, Bacia JJ, Barsanti JA, et al. Ibuprofen toxicosis in a dog. J Am Vet Med Assoc 1986, 188(9):918-919.
7. Cosenza SF Drug-induced gastroduodenal ulceration in dogs. Mod Vet Pract 1984, Dec:923-925.
8. McKellar QA, May SA, Lees P Pharmacolgy and therapeutics of non-steroidal anti-inflammatory drugs in the dog and cat: two individual agents. J Small Anim Pract 1991, 32:225-235.
9. Duggan DE, Hooke KF, Noll RM, et al. Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol 1975, 25:1749-1754.
10. Nap RC Nonsteroidal anti-inflammatory drugs (NSAIDs) in companion animal medicine. Tijdschr Diergeneeskd 1993, 118(Suppl 1):6S-8S.
11. Scherkl R, Frey HH Pharmacokinetics of ibuprofen in the dog. J Vet Pharmacol Ther 1987, 10:261-265.
12. Lees P, May SA, McKellar QA Pharmacology and therapeutics of nonsteroidal anti-inflammatory drugs in the dog and cat. General pharmacology. J Small Anim Pract 1991, 32:183-193.
13. Adams SS, Bough RG, Cliff EE, et al. Absorption, distribution, and toxicity of ibuprofen. Toxicol Appl Pharmacol 1969, 15:310-330.
14. Beasley VR, Trammel HL Incidence of poisonings in small animals. Current veterinary therapy X, small animal practice 1989, WB Saunders, Philadelphia. R.W. Kirk, J.D. Bonagura (Eds.).
15. Buck WB Top 25 generic agents involving dogs and cats managed by the National Animal Poison Control Center in 1992. Kirk's current therapy XII, small animal practice 1995, WB Saunders, Philadelphia. J.D. Bonagura (Ed.).
16. Willard MD Diseases of the stomach. Textbook of veterinary internal medicine 1995, vol II. WB Saunders, Philadelphia. ed 4. S.J. Ettinger, E.C. Feldman (Eds.).
17. Vane JR, Botting RM Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol 1996, 25(Suppl 102):9-21.
18. Maddison JE Corticosteroids and non-steroidal anti-inflammatory drugs. Proc Annu Semin Eq Branch Comp Anim Soc, NZ Vet Assoc 1994, 158:91-106.
19. Masferrer JL, Isakson PC, Seibert K Cyclooxygenase-2 inhibitors. Gastroenterol Clin North Am 1996, 25(2):363-372.
20. Brideau C, Kargman S, Liu S, et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res 1996, 45:68-74.
21. Frolich JC A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci 1997, 18(1):30-34.
22. Famaey JP In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Inflamm Res 1997, 46:437-446.
23. Engelhardt G Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Br J Rheumatol 1996, 35(Suppl):4-12.
24. Donnelly MT, Hawkey CJ Review article: COX-2 inhibitors-a new generation of safer NSAIDs?. Aliment Pharmacol Ther 1997, 11:227-236.
25. Hayllar J, Bjarnason I Gastroduodenal tolerability of highly specific cyclooxygenase-2 inhibitor. Ital J Gastroenterol 1996, 28(Suppl 4):30-32.
26. Wallace JL NSAID gastroenteropathy: past, present and future. Can J Gastroenterol 1996, 10(7):451-459.
27. Conlon PD Nonsteroidal drugs used in the treatment of inflammation. Vet Clin North Am Small Anim Pract 1988, 18:1115-1131.
28. Borga O, Borga B Serum protein binding on nonsteroidal antiinflammatory drugs: a comparative study. J Pharmacokinet Biopharm 1997, 25(1):63-77.
29. Galbraith EA, McKellar QA Pharmacokinetics and pharmacodynamics of piroxicam in dogs. Vet Rec 1991, 128:561-565.
30. McKellar QA, Galbraith EA, Simmons RD Pharmacokinetics and serum thromboxane inhibition of two NSAIDs when administered to dogs by the intravenous or subcutaneous route. J Small Anim Pract 1991, 32:335-340.
31. Cunningham FM, Lees P Advances in anti-inflammatory therapy. Br Vet J 1994, 150:115-134.
32. Papich MG Principles of analgesic drug therapy. Semin Vet Med Surg (Small Anim) 1997, 12(2):80-93.
33. Pearson SP, Kelberman I Gastrointestinal effects of NSAIDs. Postgrad Med 1996, 100(5):131-143.
34. Hawkey CJ Non-steroidal anti-inflammatory drug gastropathy: causes and treatments. Scand J Gastroenterol 1996, 31(Suppl 220):124-127.
35. Champion GD, Feng PH, Azuma T, et al. NSAID-induced gastrointestinal damage. Drugs 1997, 53(1):6-19.
36. Evans JMM, McMahon AD, Murray FE, et al. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 1997, 40:619-622.
37. Gutthan SP, Garcia Rodriguez LA, Raiford DS Individual nonsteroidal anti-inflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology 1997, 8(1):18-24.
38. Matzke GR Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agents. Am J Kidney Dis 1996, 28(1 Suppl 1):S63-S70.
39. Wallace JL Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 1997, 112(3):1000-1016.
40. Kawano S, Tsuji S, Sato N, et al. NSAIDs and the microcirculation of the stomach. Gastroenterol Clin North Am 1996, 25(2):299-314.
41. Strom H, Thomsen MK Effects of non-steroidal anti-inflammatory drugs on canine neutrophil chemotaxis. J Vet Pharmacol Ther 1990, 13:186-191.
42. Hansen JM, Hallas J, Lauritsen JM, et al. Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making. Scand J Gastroenterol 1996, 31:126-130.
43. Faucheron JL, Parc R Non-steroidal anti-inflammatory drug-induced colitis. Int J Colorect Dis 1996, 11:99-101.
44. Peterson WL The influences of food, beverages and NSAIDs on gastric acid secretion and mucosal integrity. Yale J Biol Med 1996, 69:81-84.
45. Lugea A, Antolin M, Mourelle M, et al. Deranged hydrophobic barrier of the rat gastroduodenal mucosa after parenteral nonsteroidal anti-inflammatory drugs. Gastroenterology 1997, 112:1931-1939.
46. Davies NM, Wright MR, Russell AS, et al. Effect of the enantiomers of flurbiprofen, ibuprofen, and ketoprofen on intestinal permeability. J Pharmaceut Sci 1996, 85(11):1170-1173.
47. Stanton ME, Bright RM Gastroduodenal ulceration in dogs. J Vet Intern Med 1989, 3:238-244.
48. Wallace MS, Zawie DA, Garvey MS Gastric ulceration in the dog secondary to the use of nonsteroidal anti-inflammatory drugs. J Am Anim Hosp Assoc 1990, 26:467-472.
49. Wen SF Nephrotoxicities of nonsteroidal anti-inflammatory drugs. J Formos Med Assoc 1997, 96(3):157-171.
50. Gutthann SP, Garcia Rodriguez LA, Raiford DS, et al. Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med 1996, 156:2433-2439.
51. de Leeuw PW Nonsteroidal anti-inflammatory drugs and hypertension. Drugs 1996, 51(2):179-187.
52. Evans AM Pharmacodynamics and pharmacokinetics of the profens: enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen. J Clin Pharmacol 1996, 36:7S-15S.
53. Nuutinen LS Risk/benefit evaluation of NSAIDs in postoperative pain therapy. Acta Anaesth Belg 1996, 47:129-133.
54. Murray MD, Brater DG Effects of NSAIDS on the kidney. Prog Drug Res 1997, 49:155-171.
55. Elwood C, Boswood A, Simpson K, et al. Renal failure after flunixin meglumine administration. Vet Rec 1992, 130(26):582-583.
56. Smitherman P Intra-operative use of flunixin meglumine. Vet Rec 1992, 131(20):471.
57. Boydell P Drug combination side effects. Vet Rec 1992, 130(14):307.
58. Rubin SI, Papich MG Nonsteroidal anti-inflammatory drugs. Current veterinary therapy X, small animal practice 1989, WB Saunders, Philadelphia. R.W. Kirk (Ed.).
59. Effects of two non-steroidal anti-inflammatory drugs (NSAIDs) and gentamicin on renal function (comment). Clin Sci (Colch) 1996, 91(2):119. Editorial Board.
60. Manuokian AV, Carson JL Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Drug Safety 1996, 15(1):64-71.
61. Harder S, Thurmann P Clinically important drug interactions with anticoagulants. Clin Pharmacokinet 1996, 30(6):416-444.
62. Browne BA, Holder EP, Rupnick L Nonsteroidal anti-inflammatory drugs and necrotizing fascitis. Am J Health Syst Pharm 1996, 53:265-269.
63. Dow SW, Rosychuk R, McChesney AE, et al. Effects of flunixin and flunixin plus prednisolone on the gastrointestinal tract of dogs. Am J Vet Res 1990, 51:1131.
64. Butterworth SJ, Weaver BMQ Drug combination side effects. Vet Record 1992, 130(12):251-252.
65. Verbeeck RJ Pharmokinetic drug interactions with nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet 1990, 19:44.
66. Daehler MH Transmural pyloric perforation associated with naproxen administration in a dog. J Am Vet Med Assoc 1986, 189(6):694-695.
67. Gfeller RW, Sandors AD Naproxen-associated duodenal ulcer complicated by perforation and bacteria- and barium sulfate-induced peritonitis in a dog. J Am Vet Med Assoc 1991, 198(4):644-646.
68. Mahaffey EA Disorders of iron metabolism. Current veterinary therapy IX 1986, WB Saunders, Philadelphia. R.W. Kirk (Ed.).
69. Weiser MG Erythrocyte responses and disorders. Textbook of veterinary internal medicine 1995, vol 2. WB Saunders, Philadelphia. ed 4. S.J. Ettinger, E.C. Feldman (Eds.).
70. Rogers K Anemia. Textbook of veterinary internal medicine 1995, Vol 2. WB Saunders, Philadelphia,. ed 4. S.J. Ettinger, E.C. Feldman (Eds.).
71. Grauer GF, Lane IF Acute renal failure. Textbook of veterinary medicine 1995, vol 2. WB Saunders, Philadelphia. ed 4. S.J. Ettinger, E.C. Feldman (Eds.).
72. Pennick DG, Matz M, Tidwell A Ultrasonography of gastric ulceration in the dog. Vet Radiol Ultrasound 1997, 38:308-312.
73. Owens JM Gastrointestinal diagnostic imaging. Kirk's Current Veterinary Therapy XII 1995, WB Saunders, Philadelphia. J.D. Bonagura (Ed.).
74. Ettinger SE, Barrett K Ascites, peritonitis, and other causes of abdominal distension. Textbook of veterinary internal medicine 1995, vol 1. WB Saunders, Philadelphia. ed 4. S.J. Ettinger, E.C. Feldman (Eds.).
75. Feldman BF Disorders of platelets. Current veterinary therapy X, small animal practice 1989, WB Saunders, Philadelphia. R.W. Kirk (Ed.).
76. Forsyth SF, Guilford WG, Lawoko CRO Endoscopic evaluation of the gastroduodenal mucosa following non-steroidal anti-inflammatory drug administration in the dog. N Z Vet J 1996, 44:179-181.
77. Strombeck DR, Guilford WG Procedures for the evaluation of pancreatic and gastrointestinal tract diseases. Small animal gastroenterology 1990, Stonegate Publishing Co, Davis, Calif. ed 2. D.R. Strombeck, W.G. Guilford (Eds.).
78. Wingfield WE Fluid selection in trauma. Veterinary emergency medicine secrets 1997, Hanley & Belfus, Philadelphia. W.E. Wingfield (Ed.).
79. Lagutchik MS Blood transfusions. Veterinary emergency medicine secrets 1997, Hanley & Belfus, Philadelphia. W.E. Wingfield (Ed.).
80. Boulay JP, Lipowitz AJ, Klausner JS Effect of cimetidine on aspirin-induced gastric hemorrhage in dogs. Am J Vet Res 1986, 47:1744-1746.
81. Ehsanullah RSB, Page MC, Tildesley G, et al. Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: controlled with ranitidine. Br Med J 1988, 297:1017-1021.
82. Robinson MG, Griffin JW, Bowers J Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal anti-inflammatory drugs. Dig Dis Sci 1989, 34:424-428.
83. Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs. N Engl J Med 1996, 334:1435-1439.
84. Brater DC Clinical pharmacology of NSAIDs. J Clin Pharmacol 1988, 28:518-524.
85. Flower RJ Analgesic-antipyretics and anti-inflammatory agents. The pharmacological basis of therapeutics 1986, Macmillan, New York. ed 7. N.G. Gilman (Ed.).
86. Blum AL Therapeutic approach to ulcer healing. Am J Med 1985, 79(Suppl 2C):8-14.
87. Cheung LY, Sonnenschein LA Effect of cimetidine on canine gastric mucosal pH and blood flow. Am J Surg 1983, 145:24-29.
88. Willard MD Gastrointestinal ulceration: update on diagnosis and treatment. Am Coll Vet Intern Med Proc 1987, 119-125.
89. Freston JW Cimetidine 1. Developments, pharmacology, and efficacy. Ann Intern Med 1982, 97:573-580.
90. Somoygi A, Gugler R Clinical pharmacokinetics of cimetidine. Clin Pharmacokin 1983, 8:463-480.
91. Singh G, Ramey DR, Morfeld D, et al. Gastrointestinal complications of non-steroidal anti-inflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study. Arch Intern Med 1996, 156:1530-1536.
92. Lancaster-Smith MJ, Jaderburg ME, Jackson DA Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut 1991, 32(3):252-255.
93. Loeb DS, Ahlquist DA, Talley MJ Management of gastroduodenopathy associated with the use of nonsteroidal anti-inflammatory drugs. Mayo Clin Proc 1992, 67(4):354-364.
94. Matikainen M, Kangos E Relation of the use of analgesics and nonsteroidal anti-inflammatory drugs (NSAIDS) to upper gastrointestinal bleeding: a preliminary report of a Finnish case-control prospective study. Pharmacol Toxicol 1994, 75(Suppl 2):51-52.
95. Ekstrom P, Carling L, Wetterhus S, et al. Omeprazole reduces the frequency of gastroduodenal lesions and dyspeptic symptoms during NSAID treatment. Gastroenterology 1995, 108:A87.
96. Oddsson E, Gudjonsson A, Thjodleifsson B Protective effect of omeprazole or ranitidine against naproxen induced damage to the human gastroduodenal mucosa (abstract). Scand J Gastroenterol 1990, 176(Suppl 25):25.
97. Whalan A, Bader JP, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcers. N Engl J Med 1989, 320(2):69-75.
98. Tarnowski AJ, Hollander D, Gerglely MS, et al. Comparison of antacid, sucralfate, cimetidine, and ranitidine in protection of the gastric mucosa against ethanol injury. Am J Med 1985, 79(Suppl 2C):8-14.
99. Tarnawski A, Hollander D, Krause WJ, et al. Does sucralfate affect the normal gastric mucosa?. Gastroenterology 1986, 90:893-905.
100. Pedrazzoli Junior J, de Almeida Pierossi M, Muscara MN, et al. Short-term sucralfate administration alters potassium diclofenac absorption in healthy male volunteers. Br J Clin Pharmacol 1997, 43(1):104-108.
101. Danjai EZ, Agrawal NM Nonsteroidal anti-inflammatory drugs: mechanisms and clinical uses. Nonsteroidal anti-inflammatory drugs 1994, Marcel Dekker, New York. ed 2. A.J. Lewis, D.E. Furst (Eds.).
102. Agrawal NM, Van Kerchkove HE, Erhardt LJ, et al. Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers: a one year study. Dig Dis Sci 1995, 40:1125-1131.
103. Elliot SL, Yeomans ND, Buchanan RR, et al. Efficacy of 12 months misoprostol as prophylaxis against NSAID-induced gastric ulcers: a placebo-controlled trial. Scand J Rheumatol 1994, 23:171-176.
104. Murtaugh RJ, Matz ME, Labato MA, et al. Use of synthetic prostaglandin E1 (misoprostol) for prevention of aspirin-induced gastroduodenal ulceration in arthritic dogs. J Am Vet Med Assoc 1993, 202(2):251-256.
105. Davies CD, Forrester D, Troy GC, et al. Effects of a prostaglandin E1 analogue, misoprostol, on renal function in dogs receiving nephrotoxic doses of gentamicin. Am J Vet Res 1998, 59(8):1048-1054.
106. Papich M Table of common drugs: approximate dosages. Kirk's current veterinary therapy XII, small animal practice 1995, WB Saunders, Philadelphia. J.D. Bonagura (Ed.).
107. Matthews KA, Doherty T, Dyson DH, et al. Nephrotoxicity in dogs associated with methoxyflurane anaesthesia and flunixin meglumine analgesia. Can Vet J 1990, 31:766-771.
108. Knapp DW, Richardson RC, Chan TCK, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994, 8:273.
109. Mbugua SW, Skoglund A, Lokken P Effects of phenylbutazone and indomethacin on the post-operative course following experimental orthopaedic surgery in dogs. Acta Vet Scand 1989, 30(1):27-35.
110. Runkel R, Chaplin M, Boost G, et al. Absorption, distribution, and excretion of naproxen in various laboratory animals and human subjects. J Pharm Sci 1972, 61:703-708.
111. Hallesy D, Shotts L, Hill R Comparative toxicology of naproxen. Scand J Rheumatol 1973, 2(Suppl):20-28.
112. Thomas NW Piroxicam-associated ulceration in a dog. Compend Cont Ed 1987, 10:1004.
113. Sumano H, DeVizcaya A, Brumbaugh G Tolerance and clinical evaluation of piroxicam in dogs. Israel J Vet Med 1996, 51(1):27-29.
114. Owens JG, Kamerling SG, Keowen ML: Anti-inflammatory effects and pharmokinetics of ketoprofen in a model of equine synovitis. Proceedings of 6th International Congress of the European Association of Veterinary Pharmacology and Toxicology, 1994.
115. Glew A, Aviad AD, Keister DM, et al. Use of ketoprofen as an antipyretic in cats. Can Vet J 1996, 37:222-225.
116. McKellar QA, Delatour P, Lees P Stereospecific pharmacodynamics and pharmacokinetics of carprofen. J Vet Pharmacol Ther 1994, 17:447-454.
117. McKellar QA, Pearson T, Bogan JA Pharmacokinetics, tolerance and serum thromboxane inhibition of carprofen in the dog. J Small Anim Pract 1990, 31:443-448.
118. Taylor PM, Delatour P, Landoni FM, et al. Pharmacodynamics and entantioselective pharmokinetics of carprofen in the cat. Res Vet Sci 1996, 60:144-151.
119. Jenkins CC, Kanara EW: First-year clinical experience with Rimadyl (carprofen): assessment of product safety, Exton, Pa, May, 1998, Pfizer animal health technical bulletin, Pfizer Animal Health.
120. MacPhail C, Lappin MR, Meyer DJ, et al. Hepatocellular toxicosis associated with administration of carprofen in 21 dogs. J Am Vet Med Assoc 1998, 212(12):1895-1901.
121. Holland M, Chastain CB Uses and misuses of aspirin. Kirk's current veterinary therapy XII, small animal practice 1995, WB Saunders, Philadelphia. J.D. Bonagura (Ed.).
122. Davis LE Clinical pharmacology of salicylates. J Am Vet Med Assoc 1980, 176:65.
123. Kauffman G Aspirin-induced gastric mucosal injury: lessons learned from animal models. Gastroenterology 1989, 96:606-614.
124. Guslandi M Gastric toxicity of antiplatelet therapy with low-dose aspirin. Drugs 1997, 53(1):1-5.
125. Haggert G, McCormick G, Frank P et al: Temporal pattern of gastric mucosal damage in beagle dogs dosed daily with aspirin over a four week period (abstract). Proceedings of the 12th American College of Veterinary Internal Medicine Forum, San Francisco, 1994.
126. Schubert TA Salicylate-induced seizures in a dog. J Am Vet Med Assoc 1984, 185:1000.
127. Proudfoot AT Salicylates and salicylamide. Clinical management of poisoning and drug overdose 1990, WB Saunders, Philadelphia. L.M. Haddad, J.F. Winchester (Eds.).
128. Cribb AE Adverse effects of NSAIDs. Clinical pharmacology, principles and practice 1998, Western Veterinary Conference, Las Vegas, Monograph Series 982. P.M. Dowling (Ed.).
129. Cribb AE Use of NSAIDs as antiinflammatory agents. Clinical pharmacology, principles and practice 1998, Western Veterinary Conference, Las Vegas, Monograph Series 982. P.M. Dowling (Ed.).